Canadian surge for BMS Parkinson's drug after generic discontinued
This article was originally published in Scrip
Executive Summary
After just seven months on the Canadian market, Apotex has discontinued making its Parkinson's treatment Apo-Levocarb CR 200/50 (levodopa/carbidopa CR tablets), a generic version of Bristol-Myers Squibb's Sinemet CR.